We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » High Court Denies GSK, Teva Appeal on Lamictal Pay-for-Delay
High Court Denies GSK, Teva Appeal on Lamictal Pay-for-Delay
The U.S. Supreme Court has paved the way for non-cash patent settlements to trigger antitrust scrutiny after it refused to hear a case involving GlaxoSmithKline’s epilepsy therapy Lamictal.